This function(s) are likely to be associated with nuclear presence [13], since we found that nuclear expression of BLCAP was associated with poor outcome (HR = 1.84 [95%CI 0.98–3.48]) for women with lobular carcinomas displaying nuclear BLCAP expression, even after adjusting for the influence of several variables (age, tumor size, BRE grade, ER status, and nodal status)(P = 0.042). The gene discussed is BLCAP; the disease is breast lobular carcinoma.